Evaluation of β-cyclodextrin-modified gemini surfactant-based delivery systems in melanoma models

Novel drug delivery systems are developed to improve the biological behavior of poorly soluble drugs and to improve therapeutic outcomes. In melanoma therapy, the goal is efficient drug delivery and mitigation of drug resistance. Melphalan (Mel), a currently used therapeutic agent for melanoma, requ...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Int J Nanomedicine
Hauptverfasser: Michel, Deborah, Mohammed-Saeid, Waleed, Getson, Heather, Roy, Caitlin, Poorghorban, Masoomeh, Chitanda, Jackson M, Verrall, Ronald, Badea, Ildiko
Format: Artigo
Sprache:Inglês
Veröffentlicht: Dove Medical Press 2016
Schlagworte:
Original Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5161338/
https://ncbi.nlm.nih.gov/pubmed/28003746
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S121156
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge